115 related articles for article (PubMed ID: 23332368)
1. N-(Phenoxyalkyl)amides as MT(1) and MT(2) ligands: antioxidant properties and inhibition of Ca(2+)/CaM-dependent kinase II.
Carocci A; Catalano A; Bruno C; Lovece A; Roselli MG; Cavalluzzi MM; De Santis F; De Palma A; Rusciano MR; Illario M; Franchini C; Lentini G
Bioorg Med Chem; 2013 Feb; 21(4):847-51. PubMed ID: 23332368
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and pharmacological effects of structurally simple ligands for MT(1) and MT(2) melatonin receptors.
Carocci A; Catalano A; Lovece A; Lentini G; Duranti A; Lucini V; Pannacci M; Scaglione F; Franchini C
Bioorg Med Chem; 2010 Sep; 18(17):6496-511. PubMed ID: 20674373
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of 4-arylpiperidinyl amide and N-arylpiperdin-3-yl-cyclopropane carboxamide derivatives as novel melatonin receptor ligands.
Li G; Zhou H; Jiang Y; Keim H; Topiol SW; Poda SB; Ren Y; Chandrasena G; Doller D
Bioorg Med Chem Lett; 2011 Feb; 21(4):1236-42. PubMed ID: 21237644
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and pharmacological evaluation of pentacyclic 6a,7-dihydrodiindole and 2,3-dihydrodiindole derivatives as novel melatoninergic ligands.
Attia MI; Witt-Enderby PA; Julius J
Bioorg Med Chem; 2008 Aug; 16(16):7654-61. PubMed ID: 18657980
[TBL] [Abstract][Full Text] [Related]
5. Development of substituted N-[3-(3-methoxylphenyl)propyl] amides as MT(2)-selective melatonin agonists: improving metabolic stability.
Hu Y; Zhu J; Chan KH; Wong YH
Bioorg Med Chem; 2013 Jan; 21(2):547-52. PubMed ID: 23228808
[TBL] [Abstract][Full Text] [Related]
6. N-(substituted-anilinoethyl)amides: design, synthesis, and pharmacological characterization of a new class of melatonin receptor ligands.
Rivara S; Lodola A; Mor M; Bedini A; Spadoni G; Lucini V; Pannacci M; Fraschini F; Scaglione F; Sanchez RO; Gobbi G; Tarzia G
J Med Chem; 2007 Dec; 50(26):6618-26. PubMed ID: 18052314
[TBL] [Abstract][Full Text] [Related]
7. Analysis of structure-activity relationships for MT2 selective antagonists by melatonin MT1 and MT2 receptor models.
Rivara S; Lorenzi S; Mor M; Plazzi PV; Spadoni G; Bedini A; Tarzia G
J Med Chem; 2005 Jun; 48(12):4049-60. PubMed ID: 15943478
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and pharmacological evaluation of 1,2,3,4-tetrahydropyrazino[1,2-a]indole and 2-[(phenylmethylamino)methyl]-1H-indole analogues as novel melatoninergic ligands.
Markl C; Attia MI; Julius J; Sethi S; Witt-Enderby PA; Zlotos DP
Bioorg Med Chem; 2009 Jul; 17(13):4583-94. PubMed ID: 19473848
[TBL] [Abstract][Full Text] [Related]
9. New melatonin (MT1/MT2) ligands: design and synthesis of (8,9-dihydro-7H-furo[3,2-f]chromen-1-yl) derivatives.
Landagaray E; Ettaoussi M; Leclerc V; Traoré B; Perez V; Nosjean O; Boutin JA; Caignard DH; Delagrange P; Berthelot P; Yous S
Bioorg Med Chem; 2014 Feb; 22(3):986-96. PubMed ID: 24417958
[TBL] [Abstract][Full Text] [Related]
10. Highly Potent and Selective MT2 Melatonin Receptor Full Agonists from Conformational Analysis of 1-Benzyl-2-acylaminomethyl-tetrahydroquinolines.
Spadoni G; Bedini A; Lucarini S; Mari M; Caignard DH; Boutin JA; Delagrange P; Lucini V; Scaglione F; Lodola A; Zanardi F; Pala D; Mor M; Rivara S
J Med Chem; 2015 Sep; 58(18):7512-25. PubMed ID: 26334942
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and functional characterization of substituted isoquinolinones as MT2-selective melatoninergic ligands.
Hu Y; Chan KH; He X; Ho MK; Wong YH
PLoS One; 2014; 9(12):e113638. PubMed ID: 25479338
[TBL] [Abstract][Full Text] [Related]
12. Molecular pharmacology of the mouse melatonin receptors MT₁ and MT₂.
Devavry S; Legros C; Brasseur C; Cohen W; Guenin SP; Delagrange P; Malpaux B; Ouvry C; Cogé F; Nosjean O; Boutin JA
Eur J Pharmacol; 2012 Feb; 677(1-3):15-21. PubMed ID: 22202844
[TBL] [Abstract][Full Text] [Related]
13. New coumarin-based fluorescent melatonin ligands. Design, synthesis and pharmacological characterization.
de la Fuente Revenga M; Herrera-Arozamena C; Fernández-Sáez N; Barco G; García-Orue I; Sugden D; Rivara S; Rodríguez-Franco MI
Eur J Med Chem; 2015 Oct; 103():370-3. PubMed ID: 26367450
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in melatonin receptor ligands.
Zlotos DP
Arch Pharm (Weinheim); 2005 Jun; 338(5-6):229-47. PubMed ID: 15952241
[TBL] [Abstract][Full Text] [Related]
15. Efficient synthesis of hexahydroindenopyridines and their potential as melatoninergic ligands.
Párraga J; Moreno L; Diaz A; El Aouad N; Galán A; Sanz MJ; Caignard DH; Figadère B; Cabedo N; Cortes D
Eur J Med Chem; 2014 Oct; 86():700-9. PubMed ID: 25232966
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of substituted N-[3-(3-methoxyphenyl)propyl] amides as highly potent MT(2)-selective melatonin ligands.
Hu Y; Ho MK; Chan KH; New DC; Wong YH
Bioorg Med Chem Lett; 2010 Apr; 20(8):2582-5. PubMed ID: 20227878
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of N-(3,3-diphenylpropenyl)alkanamides as a novel class of high-affinity MT2-selective melatonin receptor ligands.
Bedini A; Spadoni G; Gatti G; Lucarini S; Tarzia G; Rivara S; Lorenzi S; Lodola A; Mor M; Lucini V; Pannacci M; Scaglione F
J Med Chem; 2006 Dec; 49(25):7393-403. PubMed ID: 17149869
[TBL] [Abstract][Full Text] [Related]
18. N-Acetyl-5-arylalkoxytryptamine analogs: probing the melatonin receptors for MT(1) -selectivity.
Markl C; Clafshenkel WP; Attia MI; Sethi S; Witt-Enderby PA; Zlotos DP
Arch Pharm (Weinheim); 2011 Oct; 344(10):666-74. PubMed ID: 21887801
[TBL] [Abstract][Full Text] [Related]
19. Homology modeling of MT1 and MT2 receptors.
Farce A; Chugunov AO; Logé C; Sabaouni A; Yous S; Dilly S; Renault N; Vergoten G; Efremov RG; Lesieur D; Chavatte P
Eur J Med Chem; 2008 Sep; 43(9):1926-44. PubMed ID: 18255198
[TBL] [Abstract][Full Text] [Related]
20. MT1-selective melatonin receptor ligands: synthesis, pharmacological evaluation, and molecular dynamics investigation of N-{[(3-O-substituted)anilino]alkyl}amides.
Rivara S; Pala D; Lodola A; Mor M; Lucini V; Dugnani S; Scaglione F; Bedini A; Lucarini S; Tarzia G; Spadoni G
ChemMedChem; 2012 Nov; 7(11):1954-64. PubMed ID: 22927210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
